Assenagon Asset Management S.A. Meridian Bioscience Inc Transaction History

Assenagon Asset Management S.A.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$30.9 - $33.55 $3.1 Million - $3.36 Million	100,256 Added 55.65%	280,426 $8.84 Million
Q2 2022 Jul 27, 2022	BUY	$23.75 - $31.69 $1.26 Million - $1.68 Million	52,963 Added 41.64%	180,170 $5.48 Million
Q1 2022 Apr 25, 2022	SELL	$19.97 - $26.94 $1.85 Million - $2.49 Million	-92,449 Reduced 42.09%	127,207 $3.3 Million
Q4 2021 Feb 01, 2022	BUY	$17.46 - $21.61 $3.84 Million - $4.75 Million	219,656 New	219,656 $4.48 Million
Q2 2020 Jul 21, 2020	SELL	$7.84 - $23.29 $4.76 Million - $14.1 Million	-606,621 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$5.57 - $11.5 $517,809 - $1.07 Million	92,964 Added 18.1%	606,621 $5.1 Million
Q4 2019 Jan 17, 2020	BUY	$7.9 - $10.14 $1.37 Million - $1.75 Million	172,857 Added 50.72%	513,657 $5.02 Million
Q3 2019 Oct 16, 2019	SELL	$9.17 - $12.01 $3.41 Million - $4.47 Million	-371,789 Reduced 52.17%	340,800 $3.23 Million
Q2 2019 Aug 12, 2019	BUY	$10.88 - $17.6 $7.75 Million - $12.5 Million	712,589 New	712,589 $8.47 Million
Q1 2019 Apr 26, 2019	SELL	$15.51 - $17.61 $999,960 - $1.14 Million	-64,472 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$14.52 - $19.72 $3.26 Million - $4.42 Million	-224,198 Reduced 77.67%	64,472 $1.12 Million
Q3 2018 Oct 29, 2018	BUY	$14.85 - $16.35 $4.29 Million - $4.72 Million	288,670 New	288,670 $4.3 Million
Q1 2018 Apr 30, 2018	SELL	$13.8 - $16.2 $3.71 Million - $4.36 Million	-268,889 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$13.55 - $15.8 $3.64 Million - $4.25 Million	268,889	268,889 $3.76 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.